checkAd

     322  0 Kommentare DBV Technologies S.A. Announces Proposed Global Offering - Seite 3

    DBV Technologies ordinary shares are traded on segment C of Euronext Paris (Ticker: DBV, ISIN code: FR0010417345).

    Forward Looking Statements

    This press release contains forward-looking statements, including statements about the proposed timing and size of the global offering and the allocation of shares across these offerings.  These forward-looking statements are not promises or guarantees and involve substantial risks and uncertainties. Among the factors that could cause actual results to differ materially from those described or projected herein include uncertainties associated generally with research and development, clinical trials and related regulatory reviews and approvals, and the risk that historical clinical trial results may not be predictive of future trial results.  A further list and description of these risks, uncertainties and other risks can be found in the Company's regulatory filings with the French Autorité des Marchés Financiers.  Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. DBV Technologies undertakes no obligation to update or revise the information contained in this Press Release, whether as a result of new information, future events or circumstances or otherwise.


    Lesen Sie auch

    DBV Technologies Contacts

    David Schilansky
    Chief Financial Officer
    Tel. : +33(0)1 55 42 78 78
    david.schilansky@dbv-technologies.com

     
     
    Susanna Mesa
    VP Finance, US Investor Relations & Strategy
    Tel. : +1 917-346-3447
    susanna.mesa@dbv-technologies.com
    Nathalie Donne
    Director, Corporate Communication & Business Development
    Tel. : +33(0)1 55 42 78 78
    nathalie.donne@dbv-technologies.com
     

    DBV IR and Media Contacts

     
     
    The Trout Group
    U.S. Investor Relations
    Todd James
    Tel. : +1 646-378-2926
    tjames@troutgroup.com
    Rooney & Associates
    Media Relations
    Marion Janic
    Tel. : +1-212-223-4017
    mjanic@rooneyco.com



    This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
    The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
    Source: DBV Technologies via Globenewswire

    HUG#1864291
    Seite 3 von 3



    GlobeNewswire
    0 Follower
    Autor folgen

    Verfasst von GlobeNewswire
    DBV Technologies S.A. Announces Proposed Global Offering - Seite 3 DBV Technologies S.A. Announces Proposed Global Offering Bagneux, France - October 20, 2014 - DBV Technologies (Euronext: DBV - ISIN: FR0010417345), a clinical-stage specialty biopharmaceutical company announced today that it intends to offer and …